$XXII
22nd Century Group, Inc.

2018 Q4 Form 10-Q Financial Statement

#000114420418057971 Filed on November 07, 2018

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2017 Q3
Revenue $7.135M $6.260M $4.531M
YoY Change 20.1% 38.17% 46.27%
Cost Of Revenue $6.620M $6.109M $4.871M
YoY Change 12.79% 25.41% 48.51%
Gross Profit $514.7K $150.9K -$340.4K
YoY Change 620.84% -144.35% 84.36%
Gross Profit Margin 7.21% 2.41% -7.51%
Selling, General & Admin $2.237M $1.998M $1.914M
YoY Change -5.99% 4.36% 26.79%
% of Gross Profit 434.67% 1323.6%
Research & Development $3.682M $4.010M $784.6K
YoY Change 201.78% 411.07% 13.71%
% of Gross Profit 715.26% 2656.4%
Depreciation & Amortization $396.0K $132.8K $88.71K
YoY Change 52.31% 49.75% -57.76%
% of Gross Profit 76.93% 88.01%
Operating Expenses $6.315M $6.360M $2.934M
YoY Change 64.46% 116.78% 21.67%
Operating Profit -$5.801M -$6.209M -$3.274M
YoY Change 53.72% 89.64% 26.13%
Interest Expense -$3.119M $4.431K $6.984K
YoY Change -7897.23% -36.55% -108.73%
% of Operating Profit
Other Income/Expense, Net -$9.790M $12.51M -$42.55K
YoY Change -29506.83% -49.45%
Pretax Income -$8.919M $6.305M -$3.317M
YoY Change 138.49% -290.09% 23.76%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$8.919M $6.305M -$3.317M
YoY Change 138.77% -290.09% 23.76%
Net Earnings / Revenue -125.01% 100.71% -73.2%
Basic Earnings Per Share $0.05 -$0.03
Diluted Earnings Per Share -$0.07 $0.04 -$0.03
COMMON SHARES
Basic Shares Outstanding 124.4M shares 124.4M shares 100.7M shares
Diluted Shares Outstanding 144.4M shares 100.7M shares

Balance Sheet

Concept 2018 Q4 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.35M $62.12M $15.02M
YoY Change -10.04% 313.59% 189.4%
Cash & Equivalents $604.9K $759.2K $15.02M
Short-Term Investments $55.75M $61.36M
Other Short-Term Assets $928.4K $1.280M $540.0K
YoY Change 23.79% 137.05% 31.71%
Inventory $3.044M $3.330M $4.030M
Prepaid Expenses
Receivables $871.3K $936.2K $130.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $61.20M $67.67M $19.73M
YoY Change -9.5% 242.97% 127.57%
LONG-TERM ASSETS
Property, Plant & Equipment $3.261M $3.307M $3.100M
YoY Change -1.67% 6.66% 26.53%
Goodwill
YoY Change
Intangibles $9.752M $8.710M
YoY Change 31.15%
Long-Term Investments $3.092M $6.731M $1.370M
YoY Change 125.72% 391.32% 30.48%
Other Assets
YoY Change
Total Long-Term Assets $16.10M $18.75M $11.93M
YoY Change 32.9% 57.15% 9.45%
TOTAL ASSETS
Total Short-Term Assets $61.20M $67.67M $19.73M
Total Long-Term Assets $16.10M $18.75M $11.93M
Total Assets $77.30M $86.42M $31.66M
YoY Change -3.06% 172.95% 61.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.575M $3.853M $1.630M
YoY Change 23.75% 136.39% 18.12%
Accrued Expenses $1.826M $1.902M $1.350M
YoY Change -8.11% 40.91% 5.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $689.2K $392.7K $330.0K
YoY Change 19.0% 0.0%
Total Short-Term Liabilities $5.174M $6.634M $3.460M
YoY Change 19.95% 91.74% 15.72%
LONG-TERM LIABILITIES
Long-Term Debt $848.2K $287.0K $0.00
YoY Change -100.0%
Other Long-Term Liabilities $0.00 $0.00 $200.0K
YoY Change -100.0% 100.0%
Total Long-Term Liabilities $848.2K $287.0K $200.0K
YoY Change 43.49% -51.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.174M $6.634M $3.460M
Total Long-Term Liabilities $848.2K $287.0K $200.0K
Total Liabilities $6.022M $6.921M $3.660M
YoY Change 39.61% 89.1% 7.65%
SHAREHOLDERS EQUITY
Retained Earnings -$99.13M -$90.22M
YoY Change 8.74%
Common Stock $1.246K $1.244K
YoY Change 0.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $71.28M $79.49M $28.00M
YoY Change
Total Liabilities & Shareholders Equity $77.30M $86.42M $31.66M
YoY Change -3.06% 172.95% 61.78%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income -$8.919M $6.305M -$3.317M
YoY Change 138.77% -290.09% 23.76%
Depreciation, Depletion And Amortization $396.0K $132.8K $88.71K
YoY Change 52.31% 49.75% -57.76%
Cash From Operating Activities -$5.283M -$4.172M -$2.570M
YoY Change 115.62% 62.32% 22.97%
INVESTING ACTIVITIES
Capital Expenditures -$338.2K -$178.8K -$180.0K
YoY Change 141.59% -0.68% 28.57%
Acquisitions
YoY Change
Other Investing Activities $5.539M $1.743M -$880.0K
YoY Change -109.35% -298.02% 700.0%
Cash From Investing Activities $5.201M $1.554M -$1.050M
YoY Change -108.76% -247.98% 337.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -72.89K -2.500K 6.170M
YoY Change -100.14% -100.04% 31.84%
NET CHANGE
Cash From Operating Activities -5.283M -4.172M -2.570M
Cash From Investing Activities 5.201M 1.554M -1.050M
Cash From Financing Activities -72.89K -2.500K 6.170M
Net Change In Cash -154.3K -2.620M 2.550M
YoY Change -98.64% -202.76% 8.51%
FREE CASH FLOW
Cash From Operating Activities -$5.283M -$4.172M -$2.570M
Capital Expenditures -$338.2K -$178.8K -$180.0K
Free Cash Flow -$4.944M -$3.993M -$2.390M
YoY Change 114.04% 67.06% 22.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Trading Symbol
TradingSymbol
XXII
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
124401468 shares
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2018-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
22nd Century Group, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001347858
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Small Business
EntitySmallBusiness
false
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
1236 USD
CY2018Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
169696744 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
166592536 USD
CY2018Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2018Q3 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
1714923 USD
CY2017Q4 xxii Inventory Tobacco Leaf Gross
InventoryTobaccoLeafGross
1552474 USD
CY2018Q3 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
237995 USD
CY2018Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
219171 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
557648 USD
CY2017Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
145934 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
429832 USD
CY2018Q3 us-gaap Advertising Expense
AdvertisingExpense
7000 USD
us-gaap Advertising Expense
AdvertisingExpense
23000 USD
CY2017Q3 us-gaap Advertising Expense
AdvertisingExpense
6000 USD
us-gaap Advertising Expense
AdvertisingExpense
49000 USD
CY2018Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
160000 USD
CY2017Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
195000 USD
CY2017Q4 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
289004 USD
CY2018Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1537349 USD
CY2017Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1636059 USD
CY2018Q3 xxii Inventorytobacco Leaf Net
InventorytobaccoLeafNet
3490267 USD
CY2017Q4 xxii Inventorytobacco Leaf Net
InventorytobaccoLeafNet
3477537 USD
CY2018Q3 us-gaap Common Stock Value
CommonStockValue
1244 USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4313206 USD
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6634239 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79739406 USD
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
86415590 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
79494380 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-91167572 USD
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-90215082 USD
CY2017Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
216490 USD
CY2018Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 USD
CY2017Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
28350 USD
CY2018Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
486010 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1987675 USD
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1902350 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2080691 USD
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3853193 USD
CY2017Q4 us-gaap Assets
Assets
79739406 USD
CY2018Q3 us-gaap Assets
Assets
86415590 USD
CY2017Q4 xxii Assests Noncurrent Excluding Property Plant And Equipment Net
AssestsNoncurrentExcludingPropertyPlantAndEquipmentNet
8801904 USD
CY2018Q3 xxii Assests Noncurrent Excluding Property Plant And Equipment Net
AssestsNoncurrentExcludingPropertyPlantAndEquipmentNet
15441087 USD
CY2017Q4 us-gaap Long Term Investments
LongTermInvestments
1366493 USD
CY2018Q3 us-gaap Long Term Investments
LongTermInvestments
6731114 USD
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7435411 USD
CY2018Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8709973 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3316047 USD
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3306601 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
67621455 USD
CY2018Q3 us-gaap Assets Current
AssetsCurrent
67667902 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
746805 USD
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1280087 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
3282537 USD
CY2018Q3 us-gaap Inventory Net
InventoryNet
3330267 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
957066 USD
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
936225 USD
CY2017Q4 us-gaap Short Term Investments
ShortTermInvestments
58975513 USD
CY2018Q3 us-gaap Short Term Investments
ShortTermInvestments
61362113 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3659534 USD
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
759210 USD
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4930073 USD
CY2018Q3 us-gaap Depreciation
Depreciation
132846 USD
us-gaap Depreciation
Depreciation
388668 USD
CY2017Q3 us-gaap Depreciation
Depreciation
88711 USD
us-gaap Depreciation
Depreciation
265296 USD
CY2018Q3 us-gaap Revenues
Revenues
6260158 USD
CY2017Q3 us-gaap Revenues
Revenues
4530865 USD
CY2018Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6109209 USD
CY2017Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4871234 USD
CY2018Q3 us-gaap Gross Profit
GrossProfit
150949 USD
CY2017Q3 us-gaap Gross Profit
GrossProfit
-340369 USD
CY2018Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4009808 USD
CY2017Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
784587 USD
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1759254 USD
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1635226 USD
CY2018Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
238704 USD
CY2017Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
279254 USD
CY2018Q3 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
219171 USD
CY2017Q3 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
145934 USD
CY2018Q3 us-gaap Operating Expenses
OperatingExpenses
6359783 USD
CY2017Q3 us-gaap Operating Expenses
OperatingExpenses
2933712 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6208834 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3274081 USD
CY2018Q3 xxii Gain Loss From Warrant Liability
GainLossFromWarrantLiability
0 USD
CY2017Q3 xxii Gain Loss From Warrant Liability
GainLossFromWarrantLiability
-55886 USD
CY2018Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-6272 USD
CY2017Q3 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
CY2017Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 USD
CY2018Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
255155 USD
CY2017Q3 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
20317 USD
us-gaap Revenues
Revenues
19291110 USD
us-gaap Revenues
Revenues
10659588 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18906869 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11438909 USD
us-gaap Gross Profit
GrossProfit
384241 USD
us-gaap Gross Profit
GrossProfit
-779321 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11307984 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2148725 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5706617 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5060823 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
641442 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
842558 USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
557648 USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
429832 USD
us-gaap Operating Expenses
OperatingExpenses
18602359 USD
us-gaap Operating Expenses
OperatingExpenses
8747234 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-18218118 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-9526555 USD
xxii Gain Loss From Warrant Liability
GainLossFromWarrantLiability
48711 USD
xxii Gain Loss From Warrant Liability
GainLossFromWarrantLiability
-138813 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-48461 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
346180 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
758665 USD
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4551420 USD
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1623472 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1235373 USD
CY2018Q3 xxii Number Of Noncash Warrants Exercised
NumberOfNoncashWarrantsExercised
94721 shares
xxii Number Of Noncash Warrants Exercised
NumberOfNoncashWarrantsExercised
794869 shares
CY2017 xxii Warrants Expired And Unexercised
WarrantsExpiredAndUnexercised
223814 shares
CY2017 xxii Number Of Warrants Exercised On Cashless Basis
NumberOfWarrantsExercisedOnCashlessBasis
1286277 shares
CY2018Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
48711 USD
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12513488 USD
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-42553 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6304654 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3316634 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2018Q3 us-gaap Interest Expense
InterestExpense
4431 USD
CY2017Q3 us-gaap Interest Expense
InterestExpense
6984 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
19170608 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
233020 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
952490 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9293535 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
48197 USD
us-gaap Interest Expense
InterestExpense
4431 USD
us-gaap Interest Expense
InterestExpense
22544 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
75426200 USD
xxii Stock Issued During Period Value Warrants Exercise
StockIssuedDuringPeriodValueWarrantsExercise
0 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
217500 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2718937 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
856931 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
621612 USD
xxii Amortization Of License Fees
AmortizationOfLicenseFees
89385 USD
xxii Amortization Of License Fees
AmortizationOfLicenseFees
73516 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
10070244 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
346180 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-48461 USD
us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
0 USD
xxii Gain Loss From Warrant Liability
GainLossFromWarrantLiability
48711 USD
xxii Gain Loss From Warrant Liability
GainLossFromWarrantLiability
-138813 USD
us-gaap Accretion Expense
AccretionExpense
4431 USD
us-gaap Accretion Expense
AccretionExpense
22544 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2718937 USD
us-gaap Share Based Compensation
ShareBasedCompensation
582398 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-10000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20841 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
75205 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12730 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1036478 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
533282 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
347384 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1420417 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
53740 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-85325 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-93882 USD
xxii Increase Decrease In Accrued Severance
IncreaseDecreaseInAccruedSeverance
0 USD
xxii Increase Decrease In Accrued Severance
IncreaseDecreaseInAccruedSeverance
-164423 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12561619 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9620986 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
318773 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
312804 USD
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
365349 USD
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
892186 USD
us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
30465534 USD
us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
0 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
32889120 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9943795 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1204990 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-282500 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12380358 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2900324 USD
CY2016Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
58681 USD
us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
48711 USD
CY2017 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
157809 USD
CY2017Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
216490 USD
CY2018Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
0 USD
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13781921 shares
CY2017 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
-1470027 shares
CY2017 xxii Number Of Warrants Expired
NumberOfWarrantsExpired
223814 shares
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
12088080 shares
CY2018Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
11293211 shares
CY2018Q3 us-gaap Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
225000 USD
xxii Milestone Payment
MilestonePayment
150000 USD
CY2018Q3 xxii Capitalized Patent Costs Gross
CapitalizedPatentCostsGross
81505 USD
xxii Capitalized Patent Costs Gross
CapitalizedPatentCostsGross
81584 USD
CY2017Q3 xxii Capitalized Patent Costs Gross
CapitalizedPatentCostsGross
236 USD
xxii Capitalized Patent Costs Gross
CapitalizedPatentCostsGross
30102 USD
CY2018Q3 xxii Minimum Annual Royalties In Year Four
MinimumAnnualRoyaltiesInYearFour
25000 USD
CY2018Q3 xxii Minimum Annual Royalties After Year Four
MinimumAnnualRoyaltiesAfterYearFour
50000 USD
CY2018Q4 xxii Minimum Annual Royalties In Year One
MinimumAnnualRoyaltiesInYearOne
10000 USD
CY2018Q3 xxii Minimum Annua Lroyalties In Year Two
MinimumAnnuaLroyaltiesInYearTwo
15000 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
162408 USD
CY2014Q3 xxii License Maintenance Fees Due Current
LicenseMaintenanceFeesDueCurrent
75000 USD
CY2018Q3 xxii Lease Payments
LeasePayments
42000 USD
xxii Lease Payments
LeasePayments
127000 USD
CY2017Q3 xxii Lease Payments
LeasePayments
38000 USD
xxii Lease Payments
LeasePayments
115000 USD
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
42000 USD
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
169000 USD
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
169000 USD
CY2018Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
141000 USD
CY2016Q1 us-gaap Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
1471 USD
CY2017Q1 us-gaap Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
1219 USD
CY2018Q1 xxii Operating Leases Monthly Lease Payment
OperatingLeasesMonthlyLeasePayment
5706 USD
CY2016Q2 xxii Litigation Settlement Shares To Be Issued
LitigationSettlementSharesToBeIssued
2077555 shares
CY2016Q2 xxii Litigation Settlement Shares To Be Issued
LitigationSettlementSharesToBeIssued
2077555 shares
CY2017Q4 xxii Litigation Settlement Shares To Be Issued
LitigationSettlementSharesToBeIssued
2077555 shares
CY2018Q3 us-gaap Loss Contingency Receivable
LossContingencyReceivable
18000000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
6304654 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-3316634 USD
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
124376061 shares
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
100673834 shares
CY2018Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
20006418 shares
CY2017Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
144382479 shares
CY2017Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
100673834 shares
us-gaap Net Income Loss
NetIncomeLoss
952490 USD
us-gaap Net Income Loss
NetIncomeLoss
-9293535 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
124237003 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
94369953 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
20006418 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
144243421 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
94369953 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20006418 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19061271 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.80
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.98
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
217500 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2392207 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
750265 USD
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
11474 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 USD
CY2018Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
286971 USD
CY2017Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 USD
CY2018Q3 us-gaap Notes Payable Current
NotesPayableCurrent
392686 USD
CY2017Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2018Q3 us-gaap Liabilities
Liabilities
6921210 USD
CY2017Q4 us-gaap Liabilities
Liabilities
4313206 USD
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
39658 USD
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6344312 USD
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3316634 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
963964 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9293535 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
11474 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
500000 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 USD
xxii License Acquired With Note Payable
LicenseAcquiredWithNotePayable
1175226 USD
xxii License Acquired With Note Payable
LicenseAcquiredWithNotePayable
0 USD
xxii Inventory Reserve Adjustments
InventoryReserveAdjustments
35000 USD
xxii Inventory Reserve Adjustments
InventoryReserveAdjustments
-95000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
12380358 USD
xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
338212 USD
xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
196014 USD
xxii Machinery And Equipment Additions Included In Accounts Payable
MachineryAndEquipmentAdditionsIncludedInAccountsPayable
13873 USD
xxii Machinery And Equipment Additions Included In Accounts Payable
MachineryAndEquipmentAdditionsIncludedInAccountsPayable
38061 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1554382 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13468188 USD
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15022570 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
3558 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2018Q2 xxii Aggregate Milestone Payments To Be Made
AggregateMilestonePaymentsToBeMade
1200000 USD
CY2018Q2 xxii Milestone Payable Upon Execution Of Second Amendment
MilestonePayableUponExecutionOfSecondAmendment
500000 USD
CY2018Q2 xxii Milestone Payable On First Anniversary Of Execution Of Second Amendment
MilestonePayableOnFirstAnniversaryOfExecutionOfSecondAmendment
400000 USD
CY2018Q2 xxii Milestone Payable On Second Anniversary Of Execution Of Second Amendment
MilestonePayableOnSecondAnniversaryOfExecutionOfSecondAmendment
300000 USD
CY2018Q2 us-gaap Notes Payable
NotesPayable
1175226 USD
CY2018Q3 us-gaap Notes Payable
NotesPayable
679657 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
500000 USD
CY2018Q3 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
63832 shares
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
490012 shares
CY2017 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
12249327 shares
CY2017Q1 xxii License Expenses
LicenseExpenses
85681 USD
CY2018Q2 us-gaap Other Commitment
OtherCommitment
75000 USD
CY2018Q3 xxii License Expenses
LicenseExpenses
3135000 USD
xxii License Expenses
LicenseExpenses
7155000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0297 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0212 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9 pure
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
124401468 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
123569367 shares
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
124401468 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
123569367 shares
CY2018Q3 xxii Realized Gain Loss On Investments
RealizedGainLossOnInvestments
8345880 USD
CY2017Q3 xxii Realized Gain Loss On Investments
RealizedGainLossOnInvestments
0 USD
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144382479 shares
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
100673834 shares
xxii Realized Gain Loss On Investments
RealizedGainLossOnInvestments
8345880 USD
xxii Realized Gain Loss On Investments
RealizedGainLossOnInvestments
0 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144243421 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
94369953 shares
xxii Reclassification Of Warrant Liability To Capital In Excess Of Par
ReclassificationOfWarrantLiabilityToCapitalInExcessOfPar
167779 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
8345880 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
13051503 USD
xxii Reclassification Of Warrants Liability To Capital In Excess Of Par Value
ReclassificationOfWarrantsLiabilityToCapitalInExcessOfParValue
167779 USD
xxii Reclassification Of Warrants Liability To Capital In Excess Of Par Value
ReclassificationOfWarrantsLiabilityToCapitalInExcessOfParValue
0 USD
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Reclassifications&#160;</div></div></div><div style="color: rgb(0, 0, 0); font-family: 'times new roman', times, serif; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 48px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;;font-style:italic;display:inline;">-&#160;</div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Certain items in the 2017 financial statements have been reclassified to conform to the 2018 classification.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risk&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">-&#160;</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in financial institutions. Although the cash accounts exceed the federally insured deposit amount, management does not anticipate nonperformance by the financial institutions. Management reviews the financial viability of these institutions on a periodic basis.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">-&#160;</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y1M20D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
900000 shares
xxii June Two Thousand Seventeen Warrant Exercise Agreements Disclosure
JuneTwoThousandSeventeenWarrantExerciseAgreementsDisclosure
<div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">NOTE 3. &#8211; JUNE 2017 WARRANT EXERCISE AGREEMENTS</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: 0.43in; margin-right: 0px; background: none;"><div style="white-space: pre-line; font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></div><div style="font-family: &quot;times new roman&quot;, serif; margin-bottom: 0px; margin-top: 0px; text-indent: 0.5in; margin-right: 0px; font-size: 10pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On June 19, 2017, the Company entered into Warrant Exercise Agreements (the &#8220;Agreements&#8221;) with all the holders (the &#8220;Holders&#8221;) of outstanding warrants to purchase up to 7,043,211 shares of common stock of the Company at $1.00 per share and warrants to purchase up to 4,250,000 shares of common stock of the Company at $1.45 per share (collectively, the &#8220;Warrants&#8221;). These Warrants to purchase shares of the Company&#8217;s common stock were acquired by the Holders in registered direct offerings in October of 2016 and in July of 2016, respectively. The Company and the Holders agreed that the Holders would, subject to beneficial ownership limitations on exercise contained in the Warrants, exercise all the Warrants for&#160;</div>cash. During the second and third quarters of 2017, the Holders exercised&#160;<div style="letter-spacing: 0px; top: 0px;;display:inline;">7,043,211</div> Warrants at $1.00 per share and 4,250,000 Warrants at $1.45 per share, resulting in net proceeds to the Company in the amount of $12,336,858, after deducting expenses associated with the transaction.&#160;</div><div style="font-family: &quot;times new roman&quot;, serif; margin-bottom: 0px; margin-top: 0px; text-indent: 0.5in; margin-right: 0px; font-size: 10pt; background: none;">&#160;&#160;<div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); background: none; text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-indent: 0.5in; margin-right: 0px;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In consideration for the Holders exercising their Warrants for cash, the Company issued to each Holder a new warrant (the &#8220;New Warrants&#8221;) to purchase shares of common stock of the Company equal to the number of shares of common stock received by each Holder upon the cash exercise of the Holder&#8217;s Warrants. The terms of the New Warrants are substantially similar to the terms of the Warrants exercised, except the New Warrants (i) have an exercise price equal to $2.15 per share and (ii) are exercisable six months from the date of issuance of the New Warrants for a period of five (5) years. Accordingly, the Company issued an aggregate of 11,293,211 New Warrants to the Holders, upon exercise of the Holder&#8217;s Warrants as described above. The New Warrants had a fair value of $16,049,031 at issuance and have been recorded as an adjustment to capital in excess of par value.</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q3 xxii Realized Gain On Sale Of Common Stock
RealizedGainOnSaleOfCommonStock
3829909 USD
CY2018Q3 xxii Fair Value Of Common Stock Transferred
FairValueOfCommonStockTransferred
9221594 USD
CY2018Q3 xxii Fair Value Of Warrants
FairValueOfWarrants
2807958 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Amortization Method
FiniteLivedIntangibleAssetsAmortizationMethod
will be amortized on a straight-line basis over the last-to-expire patent, which is expected to be in 2036.
CY2018Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.15
CY2017Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
55886 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
138813 USD
CY2018Q3 xxii Minimum Annual Royalties In Year Three
MinimumAnnualRoyaltiesInYearThree
25000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
10070244 USD
CY2018Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
3923156 USD
xxii Warrant Expiration Date
WarrantExpirationDate
2020-12-20
xxii Reclassification Of Warrant Liability To Capital
ReclassificationOfWarrantLiabilityToCapital
-167779 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2018Q3 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
0 USD
CY2017Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
3000000 USD
xxii Increase In Deferred Revenue
IncreaseInDeferredRevenue
457660 USD
xxii Increase In Deferred Revenue
IncreaseInDeferredRevenue
158478 USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0 USD

Files In Submission

Name View Source Status
0001144204-18-057971-index-headers.html Edgar Link pending
0001144204-18-057971-index.html Edgar Link pending
0001144204-18-057971.txt Edgar Link pending
0001144204-18-057971-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv505630_10q.htm Edgar Link pending
tv505630_ex31-1.htm Edgar Link pending
tv505630_ex31-2.htm Edgar Link pending
tv505630_ex32-1.htm Edgar Link pending
xxii-20180930.xml Edgar Link completed
xxii-20180930.xsd Edgar Link pending
xxii-20180930_cal.xml Edgar Link unprocessable
xxii-20180930_def.xml Edgar Link unprocessable
xxii-20180930_lab.xml Edgar Link unprocessable
xxii-20180930_pre.xml Edgar Link unprocessable